- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04142853
Underlying Causes and Related Factors, and Rehabilitation Approaches
Walking-related Performance Fatigabitity in People With Multiple Sclerosis: Clinical Profile o
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Hasselt, Belgien, 3500
- Hasselt University
-
Liège, Belgien, 4000
- Centre Hospitalier Universitaire de Liege
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age between 18 and 70 years.
- MS diagnosis according to McDonald Criteria.
- Capable of walking 6 minutes (independent or with unilateral support) without stopping.
Exclusion Criteria:
- Exacerbation or relapse within last 3 months before study
- Other medical condition interfering with walking ability (e.g. cardiac or respiratory diseases, arthritis and fibromyalgia, stroke, Parkinson).
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Screening
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Persons with MS, dance group
|
Training intervention + Dance intervention
|
|
Aktiv komparator: Persons with MS, art group
|
Training intervention + Dance intervention
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Symbol Digit Modality Test (SDMT) (Kognitiv træthed)
Tidsramme: uge 11
|
hans er en kognitiv præstationstest, underbygget med fokus, hastighed og visuel scanning.
Korrekte svar sidste 30 sekunder vs første 30 sekunder
|
uge 11
|
|
Ni-hullers peg-test (NHPT)
Tidsramme: uge 11
|
Dette er en motorisk test for at vurdere deltagerens manuelle færdigheder.
Denne test registrerer den tid, deltageren skal bruge for at placere 9 stifter i pegboardet og fjerne dem igen.
|
uge 11
|
|
the Coordination test
Tidsramme: Day 1
|
Participant is seated with legs strapped in to the mounts and moves legs to the beat of a metronome to assess central motor control.
|
Day 1
|
|
TST (Triple Stimulation Technique)
Tidsramme: day 3
|
Technique in which nerves are stimulated to check guidance in the central nervous system
|
day 3
|
|
TMS (Transcranial Magnetic Stimulation)
Tidsramme: Day 3
|
Technique in which nerves are stimulated to check guidance in the central nervous system
|
Day 3
|
|
the Voluntary Drive test
Tidsramme: Day 1
|
The participant is seated in a Biodex.
While performing a leg extension the Quadriceps muscle is stimulated to check the guidance of electrical signals to the muscles.
|
Day 1
|
|
the Fatigability Index Legs
Tidsramme: Day 1
|
Participant is seated in a Biodex and a protocol is performed to establish the muscle strength and muscle endurance of the legs.
|
Day 1
|
|
Analysis of a Muscle Biopsy
Tidsramme: Day 3
|
A small piece of muscle tissue of the weakest leg will be biopsied and analyzed in the lab.
|
Day 3
|
|
the Digit Span
Tidsramme: Baseline
|
Cognitive test where numbers must be recalled in a certain order to evaluate short term memory
|
Baseline
|
|
the Digit Span
Tidsramme: Week 11
|
Cognitive test where numbers must be recalled in a certain order to evaluate short term memory
|
Week 11
|
|
the Stroop test
Tidsramme: Baseline
|
Cognitive test to evaluate attention and simultaneous processing of multiple stimuli.
|
Baseline
|
|
the Stroop test
Tidsramme: week 11
|
Cognitive test to evaluate attention and simultaneous processing of multiple stimuli.
|
week 11
|
|
the Paced Auditory Serial Addition Test (PASAT)
Tidsramme: Baseline
|
This is a cognitive test where the participant will try to retain certain numbers they hear and do math.
Correct answer last 1/3 vs first 1/3
|
Baseline
|
|
the Paced Auditory Serial Addition Test (PASAT)
Tidsramme: Week 11
|
This is a cognitive test where the participant will try to retain certain numbers they hear and do math.
Correct answer last 1/3 vs first 1/3
|
Week 11
|
|
the Symbol Digit Modality Test (SDMT) (Cognitive fatigability)
Tidsramme: Baseline
|
his is a cognitive performance test, substantiated with focus, speed, and visual scanning.
Correct answers last 30 seconds vs first 30 seconds
|
Baseline
|
|
Motor function test (lower limb muscle strength)
Tidsramme: Baseline
|
This is a motor test to assess the functional lower limb muscle strength.
The participant is asked to stand from a seated position and sit down again as fast as possible for five times in a row.
|
Baseline
|
|
Motor function test (lower limb muscle strength)
Tidsramme: week 11
|
This is a motor test to assess the functional lower limb muscle strength.
The participant is asked to stand from a seated position and sit down again as fast as possible for five times in a row.
|
week 11
|
|
25 Foot Walk (T25FW) test
Tidsramme: Baseline
|
his is a motor test at which the participant is instructed to walk 25 ft (=7,62 meter) as fast and safely as possible.
This is a quantitative performance test to assess mobility and leg function.
|
Baseline
|
|
25 Foot Walk (T25FW) test
Tidsramme: week 11
|
his is a motor test at which the participant is instructed to walk 25 ft (=7,62 meter) as fast and safely as possible.
This is a quantitative performance test to assess mobility and leg function.
|
week 11
|
|
Nine Hole Peg Test (NHPT)
Tidsramme: Baseline
|
This is a motor test to assess the participant's manual skills.
This test records the time the participant needs to place 9 pins in the pegboard and remove them again.
|
Baseline
|
|
Fatigability Index Hand
Tidsramme: Baseline
|
Grip strength will be evaluated through a Jamar dynamometer.
|
Baseline
|
|
Fatigability Index Hand
Tidsramme: week 11
|
Grip strength will be evaluated through a Jamar dynamometer.
|
week 11
|
|
Activity tracker
Tidsramme: Up to 5 days
|
A sensor will be placed around the foot and worn by the participant for 5 days and nights to evaluate physical activity and quality of sleep.
|
Up to 5 days
|
|
Glycocheck
Tidsramme: Baseline
|
A small camera will be placed under the tongue of the participant and blood vessels will be filmed to determine the quality of the blood vessels and immunity.
|
Baseline
|
|
Six minute walking test
Tidsramme: once during the observational study
|
Participant have to walk as far as they can for 6 minutes.
Total distance walked and fatigability by comparing first and last minute distance will be calculated.
|
once during the observational study
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fatigue severity scale (FSS)
Tidsramme: baseline
|
A self-report scale of nine items about fatigue, its severity and how it affects certain activities.
Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree.
This means the minimum score possible is nine and the highest is 63.
The higher the score, the more severe the fatigue is and the more it affects the person's activities.
It is simple to understand and takes an average of eight minutes to answer
|
baseline
|
|
Fatigue severity scale (FSS)
Tidsramme: week 11
|
A self-report scale of nine items about fatigue, its severity and how it affects certain activities.
Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree.
This means the minimum score possible is nine and the highest is 63.
The higher the score, the more severe the fatigue is and the more it affects the person's activities.
It is simple to understand and takes an average of eight minutes to answer
|
week 11
|
|
Modified Fatigue Impact Scale (MFIS)
Tidsramme: baseline
|
This is a short questionnaire to evaluate to impact of general fatigue.
This questionnaire measures the effects of fatigue on three levels: physical, cognitive and psychosocial.
The MFIS is a 21-item questionaire, scale 0 (never)-4 (always), scale range 0-40
|
baseline
|
|
Modified Fatigue Impact Scale (MFIS)
Tidsramme: week 11
|
This is a short questionnaire to evaluate to impact of general fatigue.
This questionnaire measures the effects of fatigue on three levels: physical, cognitive and psychosocial.The MFIS is a 21-item questionaire, scale 0 (never)-4 (always), scale range 0-40
|
week 11
|
|
Fatigue Scale of Motor and Cognitive Functions (FSMC)
Tidsramme: baseline
|
This is a short questionnaire to cognitive and motor fatigue in people with MS.
The FSMC is an assessment of MS-related cognitive and motor fatigue.
A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question.
Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).
Two subscales (mental and physical fatigue) can be made.
Items included in the subscale mental are 1-4-7-8-11-13-15-17-18-20 and items included in the subscale physical are 2-3-5-6-9-10-12-14-16-19.
|
baseline
|
|
Fatigue Scale of Motor and Cognitive Functions (FSMC)
Tidsramme: week 11
|
This is a short questionnaire to cognitive and motor fatigue in people with MS.
The FSMC is an assessment of MS-related cognitive and motor fatigue.
A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question.
Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).
Two subscales (mental and physical fatigue) can be made.
Items included in the subscale mental are 1-4-7-8-11-13-15-17-18-20 and items included in the subscale physical are 2-3-5-6-9-10-12-14-16-19.
|
week 11
|
|
Hospital Anxiety and Depression Scale (HADS)
Tidsramme: baseline
|
This is a short questionnaire that evaluates symptoms of anxiety and depression in daily life.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression..
|
baseline
|
|
Hospital Anxiety and Depression Scale (HADS)
Tidsramme: Week 11
|
This is a short questionnaire that evaluates symptoms of anxiety and depression in daily life.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
|
Week 11
|
|
The Sleep Condition Indicator (SCI)
Tidsramme: baseline
|
This is a short questionnaire to evaluate sleeping pattern and potential sleeping disorders.
The Sleep Condition Indicator (SCI) is an eight-item rating scale (4-0) that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
baseline
|
|
The Sleep Condition Indicator (SCI)
Tidsramme: week 11
|
This is a short questionnaire to evaluate sleeping pattern and potential sleeping disorders.
The Sleep Condition Indicator (SCI) is an eight-item rating scale (4-0) that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
week 11
|
|
Social Role Participation Questionnaire (SRPQ)
Tidsramme: baseline
|
This is a short questionnaire to evaluate social participation.
scale 1 (not important) - 5(very important)
|
baseline
|
|
Social Role Participation Questionnaire (SRPQ)
Tidsramme: week 11
|
This is a short questionnaire to evaluate social participation.
scale 1 (not important) - 5 (very important)
|
week 11
|
|
pre-interventionMSWS-12 score
Tidsramme: baseline
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
baseline
|
|
post-interventionMSWS-12 score
Tidsramme: baseline
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
baseline
|
|
pre-interventionMSWS-12 score
Tidsramme: week 11
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
week 11
|
|
post-interventionMSWS-12 score
Tidsramme: week 11
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
week 11
|
|
Multiple Sclerosis Impact Scale (MSIS-29)
Tidsramme: Baseline
|
This is a short self-report questionnaire used to assess the day-to-day life in the past two weeks. This questionnaire has a physical and psychological scale. The MSIS-29 is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). The physical impact score is computed by summing items number 1-20 inclusive. This score can then be transformed to a score on a scale of 0 -100 |
Baseline
|
|
Multiple Sclerosis Impact Scale (MSIS-29)
Tidsramme: week 11
|
This is a short self-report questionnaire used to assess the day-to-day life in the past two weeks. This questionnaire has a physical and psychological scale. The MSIS-29 is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). The physical impact score is computed by summing items number 1-20 inclusive. This score can then be transformed to a score on a scale of 0 -100 |
week 11
|
|
Short Form Health survey (SF-36)
Tidsramme: Baseline
|
questionnaire to measure health status.
The Optum® SF-36v2® Health Survey asks 36 questions to measure functional health and well-being from the patient's point of view.
It is a practical, reliable and valid measure of physical and mental health that can be completed in five to ten minutes.
|
Baseline
|
|
Short Form Health survey (SF-36)
Tidsramme: week 11
|
questionnaire to measure health status.
The Optum® SF-36v2® Health Survey asks 36 questions to measure functional health and well-being from the patient's point of view.
It is a practical, reliable and valid measure of physical and mental health that can be completed in five to ten minutes.
|
week 11
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- B707201835771
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Multipel sclerose
-
Baskent UniversityIkke rekrutterer endnuMULTIPL SKLEROSETyrkiet (Türkiye)
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeKlassisk Hodgkin lymfom | Lymfocytrigt klassisk Hodgkin-lymfom | Ann Arbor Stage IB Hodgkin lymfom | Ann Arbor Stage II Hodgkin lymfom | Ann Arbor Stage IIA Hodgkin lymfom | Ann Arbor Stage IIB Hodgkin lymfom | Ann Arbor Stage I Hodgkin lymfom | Ann Arbor Stage I Mixed Cellularity Klassisk Hodgkin-lymfom og andre forholdForenede Stater
Kliniske forsøg med Training intervention + Dance intervention
-
Center for Social Innovation, MassachusettsUniversity of Maryland; Dartmouth College; New York State Psychiatric InstituteAfsluttet
-
I-Shou UniversityAfsluttetLivskvalitet | Kognitiv svækkelse | Virtual realityTaiwan
-
Wissal AbassiAfsluttetInflammatoriske markører | LeverenzymerTunesien
-
VA Office of Research and DevelopmentAfsluttetÆldre mænd og kvinder med høj faldrisikoForenede Stater
-
Florida International UniversityAfsluttetAttention Deficit Hyperactivity DisorderForenede Stater
-
The Hong Kong Polytechnic UniversityRekruttering
-
University of WarsawIkke rekrutterer endnuTilpasningsforstyrrelser
-
VA Office of Research and DevelopmentAfsluttet
-
Virginia Commonwealth UniversityNRG OncologyAfsluttetProstatakræftForenede Stater
-
University of Wisconsin, MilwaukeeNational Institute of Mental Health (NIMH); University of UtahAfsluttetTourettes syndrom | Kronisk tic-lidelseForenede Stater